Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Sponsor: Jonsson Comprehensive Cancer Center
Terminated
low accrual
Other terminated trials from Jonsson Comprehensive Cancer Center
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified · Phase PHASE2 · Feb 2026
- Prostate Cancer · Phase NA · Jan 2026
- Resectable Pancreatic Carcinoma · Phase EARLY_PHASE1 · Mar 2025
- Neurofibromatosis Type 2 · Phase PHASE2 · Feb 2024
- Anatomic Stage 0 Breast Cancer AJCC v8 · Phase PHASE1 · May 2023
See all terminations from Jonsson Comprehensive Cancer Center
A observational or N/A phase clinical study on Ocular Melanoma, this trial is terminated or withdrawn. The trial is conducted by Jonsson Comprehensive Cancer Center and has accumulated 8 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Sep 2019 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
Jun 2018 — Sep 2019 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jan 2018 [monthly]
Recruiting NA
First recorded
Mar 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Jonsson Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .